カテゴリー： QYResearch, 世界

世界の顆粒球マクロファージコロニー刺激因子市場 2019年

【英語タイトル】Global Granulocyte Macrophage Colony Stimulating Factor Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X08574）・商品コード：DATA909X08574
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：102
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、顆粒球マクロファージコロニー刺激因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CG-0070、ギムシルマブ、GSK-3196165、レンジルマブ、MGN-1601、その他に、用途別には、固形腫瘍、リンパ腫、腎臓癌、肺疾患、その他にセグメント区分し、顆粒球マクロファージコロニー刺激因子の世界市場を分析しました。


・エグゼクティブ・サマリー
・顆粒球マクロファージコロニー刺激因子の世界市場概要
・顆粒球マクロファージコロニー刺激因子の製造コスト構成分析
・顆粒球マクロファージコロニー刺激因子の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・顆粒球マクロファージコロニー刺激因子の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・顆粒球マクロファージコロニー刺激因子のセグメント分析（種類別）
（CG-0070、ギムシルマブ、GSK-3196165、レンジルマブ、MGN-1601、その他）
・顆粒球マクロファージコロニー刺激因子のセグメント分析（用途別）
（固形腫瘍、リンパ腫、腎臓癌、肺疾患、その他）
・顆粒球マクロファージコロニー刺激因子の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Aduro BioTech Inc、Amgen Inc、BriaCell Therapeutics Corp、Cold Genesys Inc、GlaxoSmithKline Plc、Humanigen Inc、Mologen AG、Morphotek Inc、Sillajen Biotherapeutics、Takeda Pharmaceutical Co Ltd、）
・顆粒球マクロファージコロニー刺激因子の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Granulocyte Macrophage Colony Stimulating Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Granulocyte Macrophage Colony Stimulating Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Granulocyte Macrophage Colony Stimulating Factor market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Granulocyte Macrophage Colony Stimulating Factor in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Granulocyte Macrophage Colony Stimulating Factor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others

Segment by Application
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Granulocyte Macrophage Colony Stimulating Factor
1.1 Definition of Granulocyte Macrophage Colony Stimulating Factor
1.2 Granulocyte Macrophage Colony Stimulating Factor Segment by Type
1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate Comparison by Types (2014-2025)
1.2.2 CG-0070
1.2.3 Gimsilumab
1.2.4 GSK-3196165
1.2.5 Lenzilumab
1.2.6 MGN-1601
1.2.7 Others
1.3 Granulocyte Macrophage Colony Stimulating Factor Segment by Applications
1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Consumption Comparison by Applications (2014-2025)
1.3.2 Solid Tumor
1.3.3 Lymphoma
1.3.4 Kidney Cancer
1.3.5 Lung Disease
1.3.6 Others
1.4 Global Granulocyte Macrophage Colony Stimulating Factor Overall Market
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue (2014-2025)
1.4.2 Global Granulocyte Macrophage Colony Stimulating Factor Production (2014-2025)
1.4.3 North America Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2014-2025)
1.4.4 Europe Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2014-2025)
1.4.5 China Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2014-2025)
1.4.6 Japan Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2014-2025)
1.4.7 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2014-2025)
1.4.8 India Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Granulocyte Macrophage Colony Stimulating Factor
2.3 Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
2.4 Industry Chain Structure of Granulocyte Macrophage Colony Stimulating Factor

3 Development and Manufacturing Plants Analysis of Granulocyte Macrophage Colony Stimulating Factor
3.1 Capacity and Commercial Production Date
3.2 Global Granulocyte Macrophage Colony Stimulating Factor Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Granulocyte Macrophage Colony Stimulating Factor
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Granulocyte Macrophage Colony Stimulating Factor Production and Capacity Analysis
4.2 Granulocyte Macrophage Colony Stimulating Factor Revenue Analysis
4.3 Granulocyte Macrophage Colony Stimulating Factor Price Analysis
4.4 Market Concentration Degree

5 Granulocyte Macrophage Colony Stimulating Factor Regional Market Analysis
5.1 Granulocyte Macrophage Colony Stimulating Factor Production by Regions
5.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Production by Regions
5.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions
5.2 Granulocyte Macrophage Colony Stimulating Factor Consumption by Regions
5.3 North America Granulocyte Macrophage Colony Stimulating Factor Market Analysis
5.3.1 North America Granulocyte Macrophage Colony Stimulating Factor Production
5.3.2 North America Granulocyte Macrophage Colony Stimulating Factor Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Granulocyte Macrophage Colony Stimulating Factor Import and Export
5.4 Europe Granulocyte Macrophage Colony Stimulating Factor Market Analysis
5.4.1 Europe Granulocyte Macrophage Colony Stimulating Factor Production
5.4.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Granulocyte Macrophage Colony Stimulating Factor Import and Export
5.5 China Granulocyte Macrophage Colony Stimulating Factor Market Analysis
5.5.1 China Granulocyte Macrophage Colony Stimulating Factor Production
5.5.2 China Granulocyte Macrophage Colony Stimulating Factor Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Granulocyte Macrophage Colony Stimulating Factor Import and Export
5.6 Japan Granulocyte Macrophage Colony Stimulating Factor Market Analysis
5.6.1 Japan Granulocyte Macrophage Colony Stimulating Factor Production
5.6.2 Japan Granulocyte Macrophage Colony Stimulating Factor Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Granulocyte Macrophage Colony Stimulating Factor Import and Export
5.7 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Market Analysis
5.7.1 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Production
5.7.2 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Import and Export
5.8 India Granulocyte Macrophage Colony Stimulating Factor Market Analysis
5.8.1 India Granulocyte Macrophage Colony Stimulating Factor Production
5.8.2 India Granulocyte Macrophage Colony Stimulating Factor Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Granulocyte Macrophage Colony Stimulating Factor Import and Export

6 Granulocyte Macrophage Colony Stimulating Factor Segment Market Analysis (by Type)
6.1 Global Granulocyte Macrophage Colony Stimulating Factor Production by Type
6.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type
6.3 Granulocyte Macrophage Colony Stimulating Factor Price by Type

7 Granulocyte Macrophage Colony Stimulating Factor Segment Market Analysis (by Application)
7.1 Global Granulocyte Macrophage Colony Stimulating Factor Consumption by Application
7.2 Global Granulocyte Macrophage Colony Stimulating Factor Consumption Market Share by Application (2014-2019)

8 Granulocyte Macrophage Colony Stimulating Factor Major Manufacturers Analysis
8.1 Aduro BioTech Inc
8.1.1 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
8.1.2 Aduro BioTech Inc Product Introduction, Application and Specification
8.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen Inc
8.2.1 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
8.2.2 Amgen Inc Product Introduction, Application and Specification
8.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 BriaCell Therapeutics Corp
8.3.1 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
8.3.2 BriaCell Therapeutics Corp Product Introduction, Application and Specification
8.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cold Genesys Inc
8.4.1 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
8.4.2 Cold Genesys Inc Product Introduction, Application and Specification
8.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 GlaxoSmithKline Plc
8.5.1 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
8.5.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Humanigen Inc
8.6.1 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
8.6.2 Humanigen Inc Product Introduction, Application and Specification
8.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Mologen AG
8.7.1 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
8.7.2 Mologen AG Product Introduction, Application and Specification
8.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Morphotek Inc
8.8.1 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
8.8.2 Morphotek Inc Product Introduction, Application and Specification
8.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Sillajen Biotherapeutics
8.9.1 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
8.9.2 Sillajen Biotherapeutics Product Introduction, Application and Specification
8.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Takeda Pharmaceutical Co Ltd
8.10.1 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
8.10.2 Takeda Pharmaceutical Co Ltd Product Introduction, Application and Specification
8.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Granulocyte Macrophage Colony Stimulating Factor Market
9.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Trend Analysis
9.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size (Volume and Value) Forecast 2019-2025
9.2 Granulocyte Macrophage Colony Stimulating Factor Regional Market Trend
9.2.1 North America Granulocyte Macrophage Colony Stimulating Factor Forecast 2019-2025
9.2.2 Europe Granulocyte Macrophage Colony Stimulating Factor Forecast 2019-2025
9.2.3 China Granulocyte Macrophage Colony Stimulating Factor Forecast 2019-2025
9.2.4 Japan Granulocyte Macrophage Colony Stimulating Factor Forecast 2019-2025
9.2.5 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Forecast 2019-2025
9.2.6 India Granulocyte Macrophage Colony Stimulating Factor Forecast 2019-2025
9.3 Granulocyte Macrophage Colony Stimulating Factor Market Trend (Product Type)
9.4 Granulocyte Macrophage Colony Stimulating Factor Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Granulocyte Macrophage Colony Stimulating Factor Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Granulocyte Macrophage Colony Stimulating Factor
Table Global Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Production Market Share by Types in 2018
Figure CG-0070 Product Picture
Figure Gimsilumab Product Picture
Figure GSK-3196165 Product Picture
Figure Lenzilumab Product Picture
Figure MGN-1601 Product Picture
Figure Others Product Picture
Table Global Granulocyte Macrophage Colony Stimulating Factor Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Consumption Market Share by Applications in 2018
Figure Solid Tumor
Figure Lymphoma
Figure Kidney Cancer
Figure Lung Disease
Figure Others
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) (2014-2025)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs) (2014-2025)
Figure North America Granulocyte Macrophage Colony Stimulating Factor Market Size (Million USD) (2014-2025)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size (Million USD) (2014-2025)
Figure China Granulocyte Macrophage Colony Stimulating Factor Market Size (Million USD) (2014-2025)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Market Size (Million USD) (2014-2025)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Market Size (Million USD) (2014-2025)
Figure India Granulocyte Macrophage Colony Stimulating Factor Market Size (Million USD) (2014-2025)
Table Granulocyte Macrophage Colony Stimulating Factor Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Granulocyte Macrophage Colony Stimulating Factor in 2018
Figure Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
Figure Industry Chain Structure of Granulocyte Macrophage Colony Stimulating Factor
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Granulocyte Macrophage Colony Stimulating Factor Manufacturing Plants Distribution
Table Granulocyte Macrophage Colony Stimulating Factor Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Granulocyte Macrophage Colony Stimulating Factor Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs) of Major Manufacturers (2014-2019)
Table Granulocyte Macrophage Colony Stimulating Factor Production Market Share of Major Manufacturers (2014-2019)
Figure Granulocyte Macrophage Colony Stimulating Factor Production Share by Manufacturers in 2018
Table Granulocyte Macrophage Colony Stimulating Factor Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share of Major Manufacturers (2014-2019)
Figure Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers in 2018
Table Granulocyte Macrophage Colony Stimulating Factor Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Granulocyte Macrophage Colony Stimulating Factor Production by Regions 2014-2019 (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Production Market Share by Regions 2014-2019
Figure Global Granulocyte Macrophage Colony Stimulating Factor Production Market Share by Regions in 2018
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions 2014-2019 (Million USD)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions 2014-2019
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions in 2018
Table Global Granulocyte Macrophage Colony Stimulating Factor Consumption by Regions 2014-2019 (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Consumption Market Share by Regions 2014-2019
Figure North America Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate 2014-2019 (K Pcs)
Figure North America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million USD)
Table North America Granulocyte Macrophage Colony Stimulating Factor Production, Consumption Import and Export (K Pcs)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Production, Consumption Import and Export (K Pcs)
Figure China Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate 2014-2019 (K Pcs)
Figure China Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million USD)
Table China Granulocyte Macrophage Colony Stimulating Factor Production, Consumption Import and Export (K Pcs)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Granulocyte Macrophage Colony Stimulating Factor Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Production, Consumption Import and Export (K Pcs)
Figure India Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate 2014-2019 (K Pcs)
Figure India Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million USD)
Table India Granulocyte Macrophage Colony Stimulating Factor Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2014-2019)
Figure Global Value (Consumption) Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2014-2019)
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Production Market Share (2014-2019)
Figure Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share (2014-2019)
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Main Business and Markets Served
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Production Market Share (2014-2019)
Figure Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share (2014-2019)
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Main Business and Markets Served
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Production Market Share (2014-2019)
Figure BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share (2014-2019)
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Main Business and Markets Served
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Production Market Share (2014-2019)
Figure Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share (2014-2019)
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Main Business and Markets Served
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Main Business and Markets Served
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Production Market Share (2014-2019)
Figure Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share (2014-2019)
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Main Business and Markets Served
Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Production Market Share (2014-2019)
Figure Mologen AG Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share (2014-2019)
Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Main Business and Markets Served
Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Production Market Share (2014-2019)
Figure Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share (2014-2019)
Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Main Business and Markets Served
Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Production Market Share (2014-2019)
Figure Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share (2014-2019)
Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Main Business and Markets Served
Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Production Market Share (2014-2019)
Figure Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share (2014-2019)
Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Main Business and Markets Served
Figure Global Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Granulocyte Macrophage Colony Stimulating Factor by Type (2019-2025)
Table Global Consumption (K Pcs) of Granulocyte Macrophage Colony Stimulating Factor by Application (2019-2025)
Table Granulocyte Macrophage Colony Stimulating Factor Distributors List
Table Granulocyte Macrophage Colony Stimulating Factor Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Aduro BioTech Inc、Amgen Inc、BriaCell Therapeutics Corp、Cold Genesys Inc、GlaxoSmithKline Plc、Humanigen Inc、Mologen AG、Morphotek Inc、Sillajen Biotherapeutics、Takeda Pharmaceutical Co Ltd、

★調査レポート[世界の顆粒球マクロファージコロニー刺激因子市場 2019年] (コード：DATA909X08574)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の顆粒球マクロファージコロニー刺激因子市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のバクテリアコロニーカウンター市場 2019年
    DATA909X04334 / QYResearch / 2019年11月15日 / ※本調査レポートは、バクテリアコロニーカウンターの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、自動タイプ、手動タイプに、用途別には、医療、科学研究、試験機関、その他にセグメント区分し、バクテリアコロニーカウンターの世界市場を分析しました。 ・エグゼクティブ・サマリー ・バクテリアコロニーカウンターの世界市場概要 ・バクテリアコロニーカウンターの製造コスト構成分析 ・バクテリアコロニーカウンターの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・バクテリアコロニーカウンターの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・バクテリアコロニーカウンターのセグメント分析（種類別） （自動タイプ、手動タイプ）...The global Bacteria Colony Counter market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Bacteria Colony Counter volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bacteria Colony Counter market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Bacteria Colony Counter in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered,...
  • 世界の自動コロニーピッカー市場 2019年
    DATA909X03841 / QYResearch / 2019年11月15日 / ※本調査レポートは、自動コロニーピッカーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ロボットコロニーピッカー、その他に、用途別には、研究機関、バイオテクノロジー＆製薬産業、病院＆民間研究所、学術機関にセグメント区分し、自動コロニーピッカーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・自動コロニーピッカーの世界市場概要 ・自動コロニーピッカーの製造コスト構成分析 ・自動コロニーピッカーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・自動コロニーピッカーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・自動コロニーピッカーのセグメント分析（種類別） （ロボットコロニーピッカー、その他）...The global Automated Colony Pickers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Automated Colony Pickers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Automated Colony Pickers market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Automated Colony Pickers in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の凝固因子濃縮物市場 2019年
    DATA909X05576 / QYResearch / 2019年11月15日 / ※本調査レポートは、凝固因子濃縮物の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、凝固因子IX、凝固因子XIII、その他に、用途別には、病院と診療所、研究所、学術機関にセグメント区分し、凝固因子濃縮物の世界市場を分析しました。 ・エグゼクティブ・サマリー ・凝固因子濃縮物の世界市場概要 ・凝固因子濃縮物の製造コスト構成分析 ・凝固因子濃縮物の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・凝固因子濃縮物の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・凝固因子濃縮物のセグメント分析（種類別） （凝固因子IX、凝固因子XIII、その他）...The global Coagulation Factor Concentrate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coagulation Factor Concentrate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coagulation Factor Concentrate market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coagulation Factor Concentrate in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の凝固因子市場 2019年
    DATA909X05545 / QYResearch / 2019年11月15日 / ※本調査レポートは、凝固因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、凝固因子I、凝固因子II、凝固因子III、凝固因子IV、その他に、用途別には、病院、診療所、外来手術センターにセグメント区分し、凝固因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・凝固因子の世界市場概要 ・凝固因子の製造コスト構成分析 ・凝固因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・凝固因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・凝固因子のセグメント分析（種類別） （凝固因子I、凝固因子II、凝固因子III、凝固因子IV、その他）...The global Clotting Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Clotting Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Clotting Factor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Clotting Factor in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Clotting Factor manufacturing...
  • 世界の抗血友病因子市場 2019年
    DATA909X03653 / QYResearch / 2019年11月15日 / ※本調査レポートは、抗血友病因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、粉末、液体に、用途別には、病院、クリニックにセグメント区分し、抗血友病因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗血友病因子の世界市場概要 ・抗血友病因子の製造コスト構成分析 ・抗血友病因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗血友病因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗血友病因子のセグメント分析（種類別） （粉末、液体）...The global Antihemophilic Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Antihemophilic Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antihemophilic Factor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Antihemophilic Factor in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Antihemophilic Factor manufacturing...
  • 世界のグリア細胞株由来神経栄養因子市場 2019年
    DATA909X08492 / QYResearch / 2019年11月15日 / ※本調査レポートは、グリア細胞株由来神経栄養因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、GSK-812、LAUR-301、TW-002、AMT-090、その他に、用途別には、筋萎縮性側索硬化症、脳虚血、パーキンソン病、網膜変性、その他にセグメント区分し、グリア細胞株由来神経栄養因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・グリア細胞株由来神経栄養因子の世界市場概要 ・グリア細胞株由来神経栄養因子の製造コスト構成分析 ・グリア細胞株由来神経栄養因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・グリア細胞株由来神経栄養因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・グリア細胞株由来神経栄養因子のセグメント分析（種類別） （GSK-812、LAUR-301、TW-002、AMT-090、その他）...The global Glial Cell Line Derived Neurotrophic Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Glial Cell Line Derived Neurotrophic Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glial Cell Line Derived Neurotrophic Factor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Glial Cell Line Derived Neurotrophic Factor in North America, Europe, China,...
  • 世界の組換え第VIII因子市場 2019年
    DATA909X14171 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換え第VIII因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、200IU、250IUに、用途別には、病院、薬局にセグメント区分し、組換え第VIII因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換え第VIII因子の世界市場概要 ・組換え第VIII因子の製造コスト構成分析 ・組換え第VIII因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換え第VIII因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換え第VIII因子のセグメント分析（種類別） （200IU、250IU）...The global Recombinant Factor VIII market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Factor VIII volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Factor VIII market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Factor VIII in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の胎盤成長因子市場 2019年
    DATA909X13085 / QYResearch / 2019年11月20日 / ※本調査レポートは、胎盤成長因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アフリベルセプト、アフリベルセプトバイオシミラー、SL-186、SL-188、その他に、用途別には、分岐網膜静脈閉塞、近視、血管新生緑内障、その他にセグメント区分し、胎盤成長因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・胎盤成長因子の世界市場概要 ・胎盤成長因子の製造コスト構成分析 ・胎盤成長因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・胎盤成長因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・胎盤成長因子のセグメント分析（種類別） （アフリベルセプト、アフリベルセプトバイオシミラー、SL-186、SL-188、その他）...The global Placenta Growth Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Placenta Growth Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Placenta Growth Factor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Placenta Growth Factor in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆